Castle Biosciences (CSTL) Cash from Operations Growth (3y) (2021 - 2026)
Castle Biosciences (CSTL) Cash from Operations Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 17.81% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -12.11% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 13.13% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -11.38% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 35.64% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 14.01% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 206.88% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -3.02% |
| 10 | Castle Biosciences | 629.76 Mn | 368.04 Mn | 63.15 Mn | 4.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.54% |
| Dec 31, 2025 | 86.52% |
| Sep 30, 2025 | 85.00% |
| Jun 30, 2025 | 62.78% |
| Mar 31, 2025 | 34.45% |
| Dec 31, 2024 | 120.78% |
| Sep 30, 2024 | 79.73% |
| Jun 30, 2024 | 78.92% |
| Mar 31, 2024 | -23.47% |
| Dec 31, 2023 | 256.28% |
| Sep 30, 2023 | 54.61% |
| Jun 30, 2023 | -31.63% |
| Mar 31, 2023 | -366.24% |
| Dec 31, 2022 | -49.41% |
| Sep 30, 2022 | -107.60% |
| Jun 30, 2022 | -174.46% |
| Mar 31, 2022 | -165.14% |
| Dec 31, 2021 | 4.68% |
| Sep 30, 2021 | -48.35% |